0000899243-17-015811.txt : 20170608 0000899243-17-015811.hdr.sgml : 20170608 20170608174206 ACCESSION NUMBER: 0000899243-17-015811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170608 FILED AS OF DATE: 20170608 DATE AS OF CHANGE: 20170608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAHAM GINGER L CENTRAL INDEX KEY: 0001192601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 17901045 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS, INC. STREET 2: 885 ARAPAHOE AVENUE CITY: BOULDER STATE: CO ZIP: 80302 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-08 0 0001466301 Clovis Oncology, Inc. CLVS 0001192601 GRAHAM GINGER L C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 1 0 0 0 Stock Option (right to buy) 59.56 2017-06-08 4 A 0 10000 0.00 A 2027-06-08 Common Stock 10000 10000 D One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant. /s/ Ginger Graham 2017-06-08